Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
Usefulness of a simplified self-checking tool (Quattro Checker®) for visual field defects in glaucoma patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ishibashi Marika, Matsumoto Chota, Nomoto Hiroki, Tanabe Fumi, Okuyama Sachiko, Kusaka Shunji
Аннотация
PURPOSE: To develop and evaluate iPad Quattro Checker® (iPad QC®), a tablet-based screening tool for detecting glaucomatous visual field (VF) abnormalities.
METHODS: We evaluated three screening methods-the iPad QC®, paper-based Quattro Checker® (paper QC®), and CLOCK CHART®-in glaucoma patients across disease stages (n = 64) and in normal participants (n = 38). VF abnormalities were defined in relation to corresponding quadrants of the Humphrey Field Analyzer (HFA). Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) were calculated.
RESULTS: Among all patients, the AUCs of the iPad QC®, paper QC®, and CLOCK CHART® were 0.97, 0.94, and 0.96, respectively. The iPad QC® retained 80.2% sensitivity in early glaucoma, with an AUC of 0.90 (95% CI: 0.81-0.98). More than half of previously unaware patients recognized their VF deficits using the iPad QC®. Testing required only a few minutes, could be self-administered on a widely available tablet, and was performed under ordinary room lighting.
CONCLUSION: The iPad QC® demonstrated high sensitivity for detecting visual field abnormalities even in the early stages of glaucoma. Its capability for self-testing using widely available tablet devices, along with its ability to raise patients' awareness of VF defects, further enhances its usefulness as a practical screening tool.
METHODS: We evaluated three screening methods-the iPad QC®, paper-based Quattro Checker® (paper QC®), and CLOCK CHART®-in glaucoma patients across disease stages (n = 64) and in normal participants (n = 38). VF abnormalities were defined in relation to corresponding quadrants of the Humphrey Field Analyzer (HFA). Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) were calculated.
RESULTS: Among all patients, the AUCs of the iPad QC®, paper QC®, and CLOCK CHART® were 0.97, 0.94, and 0.96, respectively. The iPad QC® retained 80.2% sensitivity in early glaucoma, with an AUC of 0.90 (95% CI: 0.81-0.98). More than half of previously unaware patients recognized their VF deficits using the iPad QC®. Testing required only a few minutes, could be self-administered on a widely available tablet, and was performed under ordinary room lighting.
CONCLUSION: The iPad QC® demonstrated high sensitivity for detecting visual field abnormalities even in the early stages of glaucoma. Its capability for self-testing using widely available tablet devices, along with its ability to raise patients' awareness of VF defects, further enhances its usefulness as a practical screening tool.